![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/17/2914500/0/en/Processa-Pharmaceuticals-Names-Russell-L-Skibsted-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/06/11/2896777/0/en/Processa-Pharmaceuticals-Announces-Positive-Efficacy-Results-from-Preliminary-Evaluation-of-Phase-1b-Dose-escalating-Trial-with-NGC-Cap-in-Gastrointestinal-Cancer.html
https://www.globenewswire.com/news-release/2024/05/06/2875738/0/en/Processa-Pharmaceuticals-to-Participate-in-the-EF-Hutton-Annual-Global-Conference.html
https://www.globenewswire.com/news-release/2024/04/30/2872162/0/en/Processa-Pharmaceuticals-Names-Dr-Steven-Cha-Senior-Vice-President-of-Clinical-Research.html
https://www.globenewswire.com/news-release/2024/04/11/2861459/0/en/Processa-Pharmaceuticals-Presents-Two-Abstracts-at-the-AACR-Annual-Meeting-2024-Including-New-Data-on-the-NGC-Cap-Phase-1b-Trial.html
https://www.globenewswire.com/news-release/2024/03/28/2853979/0/en/Processa-Pharmaceuticals-to-Present-at-the-MedInvest-Biotech-and-Pharma-Investor-Conference.html
https://www.globenewswire.com/news-release/2024/03/25/2851598/0/en/Processa-Pharmaceuticals-to-Present-Data-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/21/2832738/0/en/Processa-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/14/2829368/0/en/Processa-Pharmaceuticals-to-Present-at-The-Winter-Wrap-Up-MicroCap-Rodeo-Winter-2024-Virtual-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824321/0/en/Processa-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Rule.html